Cargando…

Recurrence of visceral and muco-cutaneous leishmaniasis in a patient under immunosuppressive therapy

BACKGROUND: Leishmaniasis is a protozoan disease caused by parasites of the genus Leishmania, transmitted to humans by sandflies. The diagnosis of leishmaniasis is often challenging as it mimics many other infectious or malignant diseases. The disease can present in three ways: cutaneous, mucocutane...

Descripción completa

Detalles Bibliográficos
Autores principales:	Darcis, Gilles, Van der Auwera, Gert, Giot, Jean-Baptiste, Hayette, Marie-Pierre, Tassin, Françoise, Arrese Estrada, Jorge, Cnops, Lieselotte, Moutschen, Michel, de Leval, Laurence, Leonard, Philippe
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2017
Materias:	Case Report
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5501116/ https://www.ncbi.nlm.nih.gov/pubmed/28687071 http://dx.doi.org/10.1186/s12879-017-2571-x

Ejemplares similares

Hoarseness as the Presenting Symptom of Visceral Leishmaniasis with Muco-Cutaneous Lesions: A Case Report
por: MORTAZAVI, Hossein, et al.
Publicado: (2015)

Liposomal amphotericin B in travelers with cutaneous and muco-cutaneous leishmaniasis: Not a panacea
por: Guery, Romain, et al.
Publicado: (2017)

Visceral Leishmaniasis, Northern Somalia, 2013–2019
por: Aalto, Mikko K., et al.
Publicado: (2020)

Muco-cutaneous manifestations in HIV infection/AIDS
por: Benea, Vasile, et al.
Publicado: (2014)

Cytokines and Their STATs in Cutaneous and Visceral Leishmaniasis
por: Cummings, Hannah E., et al.
Publicado: (2010)

Cutaneous Leishmaniasis Due to Leishmania aethiopica
por: van Henten, Saskia, et al.
Publicado: (2019)

Imported visceral leishmaniasis and immunosuppression in seven Norwegian patients
por: Schwartz, Thomas, et al.
Publicado: (2019)

Factors associated with late presentation for HIV care in a single Belgian reference center: 2006–2017
por: Darcis, Gilles, et al.
Publicado: (2018)

Domestic Animals and Epidemiology of Visceral Leishmaniasis, Nepal
por: Bhattarai, Narayan Raj, et al.
Publicado: (2010)

Severe visceral leishmaniasis and COVID-19 coinfection in an immunosuppressed patient
por: Martins, Luciamáre Perinetti Alves, et al.
Publicado: (2022)

Minimally Invasive Microbiopsies as an Improved Sampling Method for the Diagnosis of Cutaneous Leishmaniasis
por: Churiso, Gemechu, et al.
Publicado: (2020)

Host transcriptomic signature as alternative test-of-cure in visceral leishmaniasis patients co-infected with HIV
por: Adriaensen, Wim, et al.
Publicado: (2020)

Mixed muco-cutaneous pemphigoid: Clinical and immunological features of 15 cases
por: Janela, Raphaël, et al.
Publicado: (2023)

Presentation of AIDS with Disseminated Cutaneous and Visceral Leishmaniasis in Iran
por: Davarpanah, Mohammadali, et al.
Publicado: (2015)

New epidemiological aspects of visceral and cutaneous leishmaniasis in Taza, Morocco
por: Hakkour, Maryam, et al.
Publicado: (2016)

Concomitant visceral and localized cutaneous leishmaniasis in two Moroccan infants
por: Mouttaki, Tarik, et al.
Publicado: (2018)

Visceral leishmaniasis with cutaneous involvement caused by Leishmania infantum-chagasi
por: Raja, Mohammed, et al.
Publicado: (2017)

Cutaneous parasitism in patients with American visceral leishmaniasis in an endemic area
por: Moura, Carla Riama Lopes de Pádua, et al.
Publicado: (2020)

Evaluating the Potential of Ursolic Acid as Bioproduct for Cutaneous and Visceral Leishmaniasis
por: Bilbao-Ramos, Pablo, et al.
Publicado: (2020)

Laboratory Diagnosis of Cutaneous and Visceral Leishmaniasis: Current and Future Methods
por: Reimão, Juliana Quero, et al.
Publicado: (2020)

Efficacy of Spironolactone Treatment in Murine Models of Cutaneous and Visceral Leishmaniasis
por: Andrade-Neto, Valter Viana, et al.
Publicado: (2021)

Evaluation of the CL Detect Rapid Test in Ethiopian patients suspected for Cutaneous Leishmaniasis
por: van Henten, Saskia, et al.
Publicado: (2022)

Impact of coronavirus pandemic and containment measures on HIV diagnosis
por: Darcis, Gilles, et al.
Publicado: (2020)

Miltefosine for the treatment of cutaneous leishmaniasis—A pilot study from Ethiopia
por: van Henten, Saskia, et al.
Publicado: (2021)

Penicillin in Muco-Purulent Conjunctivitis
por: Puttanna, S. T.
Publicado: (1951)

Treatment of Muco-Membranous Colitis
Publicado: (1904)

Optimization of multiple muco-cutaneous site sampling method for screening MRSA colonization in ICU
por: Datta, Priya, et al.
Publicado: (2013)

Tumor-Infiltrating CD8+ Lymphocytes Effect on Clinical Outcome of Muco-Cutaneous Melanoma
por: Rahbar, Mahtab, et al.
Publicado: (2015)

Implants in patients with oral manifestations of autoimmune or muco-cutaneous diseases – A systematic review
por: Strietzel, Frank P., et al.
Publicado: (2019)

1983. Oral Therapy with Rifampin Associated with Minocycline or Moxifloxacin in Vertebral Osteomyelitis due to Gram-Positive Micro-organisms: A Retrospective Study of 64 Cases
por: Gaspard, Laura, et al.
Publicado: (2018)

Visceral leishmaniasis
por: Sundar, Shyam
Publicado: (2015)

Extensive, Multifocal Cutaneous Leishmaniasis Presenting with Varied Morphologies in an Immunosuppressed Patient
por: Watson, Ian T., et al.
Publicado: (2019)

Correction: Epidemiology and Clinical Features of Patients with Visceral Leishmaniasis Treated by an MSF Clinic in Bakool Region, Somalia, 2004–2006
por: Raguenaud, Marie-Eve, et al.
Publicado: (2008)

Correction: Epidemiology and Clinical Features of Patients with Visceral Leishmaniasis Treated by an MSF Clinic in Bakool Region, Somalia, 2004–2006
por: Raguenaud, Marie-Eve, et al.
Publicado: (2021)

A comparison of serum selenium, zinc and copper level in visceral and cutaneous leishmaniasis
por: Farzin, Leila, et al.
Publicado: (2014)

In situ CUTANEOUS CELLULAR IMMUNE RESPONSE IN DOGS NATURALLY AFFECTED BY VISCERAL LEISHMANIASIS
por: ROSSI, Claudio Nazaretian, et al.
Publicado: (2016)

Unusual clinical presentation of cutaneous leishmaniasis in a patient with corticosteroid‐induced immunosuppression
por: Mahdavi, Maryam, et al.
Publicado: (2020)

Congenital Visceral Leishmaniasis
por: Boehme, Catharina C., et al.
Publicado: (2006)

Immunity to Visceral Leishmaniasis
por: Ali, Nahid, et al.
Publicado: (2012)

Treatment of Visceral Leishmaniasis
por: Moore, E M, et al.
Publicado: (2010)

Cannot write session to /tmp/vufind_sessions/sess_1drl3cq2vbqj1onelt0t2q4uuk